Cis-platin-Mecy as salvage chemotherapy in recurrent advanced ovarian carcinoma.

Giornale italiano di oncologia Pub Date : 1989-01-01
M Belli, G Colantuoni, B Di Iorio
{"title":"Cis-platin-Mecy as salvage chemotherapy in recurrent advanced ovarian carcinoma.","authors":"M Belli,&nbsp;G Colantuoni,&nbsp;B Di Iorio","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Cis-platin (DDP) has proved to be highly active in the treatment of ovarian adenocarcinoma. The Authors have treated 12 patients with istologically proven advanced ovarian carcinoma with a type of alternating regimen consisting of four weekly DDP courses (1 mg/kg b.w./week) followed by monthly courses high-dose methotrexate (750 mg/mq i.v.) plus cyclophosphamide (250 mg/mq for 5 days) (Mecy). The alternating regimen DDP + Mecy proved to have significant activity as a salvace chemiotherapy regimen for patients with advanced ovarian carcinoma.</p>","PeriodicalId":77541,"journal":{"name":"Giornale italiano di oncologia","volume":"9 1","pages":"31-3"},"PeriodicalIF":0.0000,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di oncologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cis-platin (DDP) has proved to be highly active in the treatment of ovarian adenocarcinoma. The Authors have treated 12 patients with istologically proven advanced ovarian carcinoma with a type of alternating regimen consisting of four weekly DDP courses (1 mg/kg b.w./week) followed by monthly courses high-dose methotrexate (750 mg/mq i.v.) plus cyclophosphamide (250 mg/mq for 5 days) (Mecy). The alternating regimen DDP + Mecy proved to have significant activity as a salvace chemiotherapy regimen for patients with advanced ovarian carcinoma.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
顺铂- mecy作为晚期卵巢癌复发的补救性化疗。
顺铂(DDP)已被证明在卵巢腺癌的治疗中具有很高的活性。作者用一种交替方案治疗了12例组织学证实的晚期卵巢癌患者,交替方案包括每周4个DDP疗程(1mg /kg体重/周),然后每月疗程高剂量甲氨蝶呤(750mg /mq静脉注射)加环磷酰胺(250mg /mq静脉注射5天)(Mecy)。DDP + Mecy交替方案被证明作为晚期卵巢癌患者的拯救性化疗方案具有显著的活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Clodronate and radiotherapy for the treatment of osteolysis caused by metastasis of breast carcinoma and non-small cell lung carcinoma. A retrospective study]. [Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms]. [Randomized study of the antiemetic efficacy of alizapride versus alizapride + dexamethasone]. [The use of ranitidine in antineoplastic polychemotherapy]. [Multiple myeloma: epidemiologic and clinical considerations].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1